kohjin glutathione Market Size, Growth Opportunity 2025-2034 Azelia I-GLO Glutathione Tablets –

Identify success criteria (50% pain reduction, specific functional milestone) guiding protocol duration and modification decisions

Suzhou-based Innovent Biologics saw its obesity drug, Mazdutide, approved by Chinese regulators last yearand according to a 2025 report released by LEK Consulting, China has more than 60 obesity drug candidates under development that are set to compete with those produced in the United States

[DOI] [PubMed] [Google Scholar] 15.Caturano A., DAngelo M., Mormone A., Russo V., Mollica M.P., Salvatore T., Galiero R., Rinaldi L., Vetrano E., Marfella R., et al

Let's break down how these two stack up side by side